调查破坏器的不稳定性

Same author

Screening for gestational diabetes mellitus: cost-utility of different screening strategies based on a woman's individual risk of disease.

Diabetologia·2010

Same author

Impact of hyperglycemia on early embryo development and embryopathy: in vitro experiments using a mouse model.

Human reproduction (Oxford, England)·2007

Same author

Fetal size and growth velocity in the prediction of the large for gestational age (LGA) infant in a glucose impaired population.

European journal of obstetrics, gynecology, and reproductive biology·2006

Same author

Two lucky escapes-placenta previa.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2006

Same author

Serum osteoprotegerin as a determinant of bone metabolism in a longitudinal study of human pregnancy and lactation.

The Journal of clinical endocrinology and metabolism·2003

Same author

Immunohistochemical tissue controls, cost-effective convenience with quality control.

Annals of diagnostic pathology·2001

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

相关实验视频

调查破坏器的不稳定性

相关概念视频

Screening for gestational diabetes mellitus: cost-utility of different screening strategies based on a woman's individual risk of disease.

Impact of hyperglycemia on early embryo development and embryopathy: in vitro experiments using a mouse model.

Fetal size and growth velocity in the prediction of the large for gestational age (LGA) infant in a glucose impaired population.

Two lucky escapes-placenta previa.

Serum osteoprotegerin as a determinant of bone metabolism in a longitudinal study of human pregnancy and lactation.

Immunohistochemical tissue controls, cost-effective convenience with quality control.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

相关实验视频

调查破坏器的不稳定性

相关概念视频

相关文章

Screening for gestational diabetes mellitus: cost-utility of different screening strategies based on a woman's individual risk of disease.

Impact of hyperglycemia on early embryo development and embryopathy: in vitro experiments using a mouse model.

Fetal size and growth velocity in the prediction of the large for gestational age (LGA) infant in a glucose impaired population.

Two lucky escapes-placenta previa.

Serum osteoprotegerin as a determinant of bone metabolism in a longitudinal study of human pregnancy and lactation.

Immunohistochemical tissue controls, cost-effective convenience with quality control.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.